Any specimen, any target, any disease. Top-down proteoform analysis and support for your research project, database, or AI stack — so you can solve biology’s hardest problems. All through the power of single-particle mass spectrometry.
ImmPro is a Techstars 2026 portfolio company and a participant in the Illinois Innovation Voucher program, run by the Illinois Science & Technology Coalition.
2026Cohort
One protein can have dozens of proteoforms, which makes peptide proteomics a guessing game. Digest the molecule and you lose the very thing you were trying to measure: which modifications co-occur, and where.
We run intact proteoform measurements on your specimens, then hand back data your team can actually build on: localised modifications, quantified proteoform ratios, and a schema that survives contact with your database.
Find the proteoform that actually separates your cohorts — in plasma, tissue, CSF or lysate — then lock it down as a targeted readout you can run again.
AAVs, ADCs, recombinant spike proteins and megadalton biotherapeutics: prove you are expressing the right thing, with drug-to-antibody and glycan heterogeneity measured on the intact molecule.
Aggregate project data into a scalable proteoform database and fix the garbage-in/garbage-out problem at the source, before it reaches your model.
See how single-particle, top-down protein mass spectrometry has been applied in the literature.
Professor and centre director at Northwestern, with 450+ publications and pioneering work in top-down proteomics.
PhD in Chemical & Biological Engineering; previously led automation at Northwestern’s Proteomics Center of Excellence.
Former Google leader with 20+ years across cloud, AI/ML and enterprise technology, including AI for genomics.
Let’s figure it out together. Tell us the specimen and the question — we’ll tell you whether proteoforms can answer it.